A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

March 25, 2025 | Comments Off on A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

Annals of Oncology 2025 January 13 [Link] E Felip, S Popat, U Dafni, K Ribi, A Pope, S Cedres, R Shah, F de Marinis, L Cove Smith, R Bernabé, M…

Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study

March 24, 2025 | Comments Off on Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study

JTO Clinical and Research Reports 2024 October 24 [Link] Prashasti Agrawal, Michael Offin, Victoria Lai, Michelle S Ginsberg, Prasad S Adusumilli, Valerie W Rusch, Jennifer L Sauter, Teresa Ho, Phillip…

Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective Study

March 21, 2025 | Comments Off on Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective Study

Oncology 2025 January 24 [Link] Tomoki Higashiyama, Kozo Kuribayashi, Hiroshi Doi, Aki Kubota, Taiichiro Otsuki, Yasuhiro Nakajima, Koji Mikami, Ryo Takahashi, Akifumi Nakamura, Daichi Fujimoto, Kazuhiro Kitajima, Toshiyuki Minami, Takashi…

Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma

March 20, 2025 | Comments Off on Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma

iScience 2024 December 2 [Link] Josephine Carpentier, Marta Freitas, Valle Morales, Katiuscia Bianchi, John Bomalaski, Peter Szlosarek, Sarah A Martin Abstract Pleural mesothelioma is a highly chemotherapy-resistant cancer. Approximately 50%…

Diagnostic Differentiation Between Two Rare Entities-Metastatic Peritoneal Mesothelioma With Duodenal Involvement and Duodenal Synovial Sarcoma: A Case Report

March 19, 2025 | Comments Off on Diagnostic Differentiation Between Two Rare Entities-Metastatic Peritoneal Mesothelioma With Duodenal Involvement and Duodenal Synovial Sarcoma: A Case Report

Cureus 2024 November 29 [Link] Bruna Haueisen Figueiredo Zwetkoff, Fauze Maluf-Filho, Filadélfio E Venco, Roberto Blasbalg, Evandro Sobroza de Mello, Mauricio Fernando de Almeida Barros Abstract This case report highlights…

Analysis of TERT mRNA Levels and Clinicopathological Features in Patients with Peritoneal Mesothelioma

March 18, 2025 | Comments Off on Analysis of TERT mRNA Levels and Clinicopathological Features in Patients with Peritoneal Mesothelioma

Cancers 2025 January 14 [Link] Antonio d’Amati, Gabriella Serio, Andrea Quaranta, Luigi Vimercati, Michelina De Giorgis, Loredana Lorusso, Mariella Errede, Vito Longo, Andrea Marzullo, Domenico Ribatti, Tiziana Annese Abstract Background/objectives:…

The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis

March 17, 2025 | Comments Off on The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis

Medicina 2025 January 16 [Link] Nadiye Sever, Sedat Yıldırım, Ali Fuat Gurbuz, Delyadil Karakaş Kılıç, Esra Zeynelgil, Yunus Emre Altintaş, Berivan Deniz Çimik, Yeşim Ağyol, Ali Kaan Güren, Pınar Erel,…

Surgical indications for pleurectomy/decortication in pleural mesothelioma based on the newly revised 9th edition of the tumour-node-metastasis classification

March 14, 2025 | Comments Off on Surgical indications for pleurectomy/decortication in pleural mesothelioma based on the newly revised 9th edition of the tumour-node-metastasis classification

Interdisciplinary Cardiovascular and Thoracic Surgery 2024 December 25 [Link] Masatoshi Kanayama, Masaru Takenaka, Takehiko Manabe, Katsuma Yoshimatsu, Rintaro Oyama, Hiroki Matsumiya, Masataka Mori, Koji Kuroda, Fumihiro Tanaka Abstract Objectives: The…

Case report: Radiological features of a case of desmoplastic malignant mesothelioma of peritoneum

March 13, 2025 | Comments Off on Case report: Radiological features of a case of desmoplastic malignant mesothelioma of peritoneum

Frontiers in Oncology 2024 December 11 [Link] Jingchao Wang, Heping Deng Abstract Desmoplastic malignant peritoneal mesothelioma (DMPM) is an extremely rare and aggressive subtype of sarcomatoid malignant mesothelioma, originating from…

Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma

March 12, 2025 | Comments Off on Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma

Journal of Experimental & Clinical Cancer Research 2024 December 21 [Link] I C Salaroglio, P Aviles, J Kopecka, A Merlini, F Napoli, L Righi, S Novello, H Sullivan, C Cuevas,…

Categories